You just read:

BioVentrix announces the 1st Revivent TC™ TransCatheter Ventricular Enhancement procedure for Ischemic Cardiomyopathy treatment at the University Heart Center Zurich in Switzerland

News provided by

BioVentrix Inc.

Sep 18, 2017, 00:00 ET